CONTROL BIONICS LIMITED — Investor Relations & Filings

Control Bionics Limited is a medical technology company specializing in advanced assistive communication and control devices. The company develops and commercializes neural interface technology designed to assist individuals with severe physical disabilities, such as Amyotrophic Lateral Sclerosis (ALS), Motor Neurone Disease (MND), and spinal cord injuries. Its flagship product, the NeuroNode, is a non-invasive, wearable sensor that utilizes electromyography (EMG) and spatial data to detect minute muscle signals or neural intent. This technology enables users to control computers, mobile devices, and speech-generating software without the need for physical movement or voice. By integrating neural signaling with eye-tracking and other assistive modalities, the company provides multi-modal solutions that enhance autonomy and communication for patients with limited motor function.